Literature DB >> 20728298

Using plausible group sizes to communicate information about medical risks.

Rocio Garcia-Retamero1, Mirta Galesic.   

Abstract

OBJECTIVE: To make informed health decisions, patients must understand and recall risks, which often involve ratios with large denominators. Grasping the meaning of such numbers may be difficult, because of limited exposure to large groups of people in either our evolutionary history or daily life.
METHODS: In an experiment (n=98), we investigated whether medical risks are easier to understand and recall if their representation is based on small, evolutionarily plausible groups of people, and whether this representation especially helps patients with low numeracy.
RESULTS: Participants-especially those with low numeracy-often disregarded and incorrectly recalled denominators of ratios representing medical risks when the denominators involved were large. Risks were easier to understand and recall if their representation was based on smaller, evolutionarily plausible groups of people.
CONCLUSIONS: Our results extend previous literature on the role of numeracy in understanding health-relevant risk communications by showing the importance of using plausible group sizes to communicate these risks to people with low numeracy. Our results also support the notion that problems in risk perception occur because of inappropriate presentation formats rather than cognitive biases. PRACTICE IMPLICATIONS: Our findings suggest suitable ways to communicate quantitative medical data-especially to people with low numeracy.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20728298     DOI: 10.1016/j.pec.2010.07.027

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  13 in total

Review 1.  Communicating genetic risk information for common disorders in the era of genomic medicine.

Authors:  Denise M Lautenbach; Kurt D Christensen; Jeffrey A Sparks; Robert C Green
Journal:  Annu Rev Genomics Hum Genet       Date:  2013       Impact factor: 8.929

Review 2.  Risk as an attribute in discrete choice experiments: a systematic review of the literature.

Authors:  Mark Harrison; Dan Rigby; Caroline Vass; Terry Flynn; Jordan Louviere; Katherine Payne
Journal:  Patient       Date:  2014       Impact factor: 3.883

3.  Using narratives and storytelling to communicate science with nonexpert audiences.

Authors:  Michael F Dahlstrom
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-15       Impact factor: 11.205

4.  Patients' expectations of screening and preventive treatments.

Authors:  Ben Hudson; Abby Zarifeh; Lorraine Young; J Elisabeth Wells
Journal:  Ann Fam Med       Date:  2012 Nov-Dec       Impact factor: 5.166

5.  Evaluation of risk communication in a mammography patient decision aid.

Authors:  Krystal A Klein; Lindsey Watson; Joan S Ash; Karen B Eden
Journal:  Patient Educ Couns       Date:  2016-02-26

6.  Pictures speak louder than numbers: on communicating medical risks to immigrants with limited non-native language proficiency.

Authors:  Rocio Garcia-Retamero; Mandeep K Dhami
Journal:  Health Expect       Date:  2011-03       Impact factor: 3.377

7.  Testing Map Features Designed to Convey the Uncertainty of Cancer Risk: Insights Gained From Assessing Judgments of Information Adequacy and Communication Goals.

Authors:  Dolores J Severtson
Journal:  Sci Commun       Date:  2015-02

8.  Numbers matter to informed patient choices: a randomized design across age and numeracy levels.

Authors:  Ellen Peters; P Sol Hart; Martin Tusler; Liana Fraenkel
Journal:  Med Decis Making       Date:  2013-11-18       Impact factor: 2.583

Review 9.  Using visual aids to improve communication of risks about health: a review.

Authors:  Rocio Garcia-Retamero; Yasmina Okan; Edward T Cokely
Journal:  ScientificWorldJournal       Date:  2012-05-02

10.  The risks we dread: a social circle account.

Authors:  Mirta Galesic; Rocio Garcia-Retamero
Journal:  PLoS One       Date:  2012-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.